Amyotrophic Lateral Sclerosis Clinical Trials in Phoenix, Arizona

8 studies are recruiting for amyotrophic lateral sclerosis in Phoenix, Arizona right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

   The goal of this clinical trial is to learn if the drug pridopidine works to treat amyotrophic lateral sclerosis in adults. It will also help to learn about the safety of pridopidine. The main question it aims to answer is: Does pridopidine slow disease progression of ALS? Researchers will compare …

   Stage

   Phase 3

   Ages

   18 to 80

   Site

   Barrow Neurological Institute, Phoenix, Arizona

   Locations

   55 in total

   Run by

   Prilenia

   See if you can join NCT07322003 on ClinicalTrials.gov

2. Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS

   PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose, uncontrolled, first-in-human study that will evaluate the safety, tolerability and effects on clinical and biomarker endpoints of intracisternal administration of Vtx-002 in participants with Amyotrophic Lateral Sclerosis (ALS). T…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   St Joseph's Hospital and medical Center - Barrow Neurological Institute, Phoenix, Arizona

   Locations

   11 in total

   Run by

   Vector Y Therapeutics

   See if you can join NCT07287397 on ClinicalTrials.gov

3. ASSESS ALL ALS Study

   The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is being funded by the National Institutes of Heal…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Barrow Neurological Institute, Phoenix, Arizona

   Locations

   37 in total

   Run by

   St. Joseph's Hospital and Medical Center, Phoenix

   See if you can join NCT06578195 on ClinicalTrials.gov

4. PREVENT ALL ALS Study

   The ALL ALS Clinical Research Consortium is establishing research to collect a wide range of samples, clinical information and measurements from Amyotrophic Lateral Sclerosis (ALS) symptomatic, ALS gene carriers and control cohorts. This consortium is begin funded by the National Institutes of Heal…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Barrow Neurological Institute, Phoenix, Arizona

   Locations

   32 in total

   Run by

   St. Joseph's Hospital and Medical Center, Phoenix

   See if you can join NCT06581861 on ClinicalTrials.gov

5. Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

   The purpose of this 2-part study is to assess the safety and efficacy of CORT113176 (dazucorilant) in patients with Amyotrophic Lateral Sclerosis (ALS).

   Stage

   Phase 2

   Ages

   18 and older

   Site

   062, Phoenix, Arizona

   Locations

   35 in total

   Run by

   Corcept Therapeutics

   See if you can join NCT05407324 on ClinicalTrials.gov

6. EIM Via the Myolex mScan as an ALS Biomarker

   Amyotrophic lateral sclerosis (ALS) has been traditionally considered incurable and untreatable. But starting in the 1990s with the introduction of Riluzole, therapies are being discovered and ultimately approved for slowing disease progression. Many pharmaceutical companies continue to seek new th…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Barrow Neurological Institute, Phoenix, Arizona

   Locations

   6 in total

   Run by

   Beth Israel Deaconess Medical Center

   See if you can join NCT06491732 on ClinicalTrials.gov

7. Precise Robotically IMplanted Brain-Computer InterfacE

   The PRIME Study is a first-in-human early feasibility study to evaluate the initial clinical safety and device functionality of the Neuralink N1 Implant and R1 Robot device designs in participants with tetraparesis or tetraplegia. The N1 Implant is a skull-mounted, wireless, rechargeable implant co…

   Stage

   Not phased

   Ages

   22 to 75

   Site

   Barrow Neurological Institute, Phoenix, Arizona

   Locations

   2 in total

   Run by

   Neuralink Corp

   See if you can join NCT06429735 on ClinicalTrials.gov

8. Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

   The goal of the study is to generate a biorepository of longitudinal biofluids-blood (plasma and serum), cerebral spinal fluid (CSF) and urine linked to genetics and longitudinal clinical information that are made available to the research community. To accomplish these goals, we will enroll 800 Am…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Barrow Neurological Institute, Phoenix, Arizona

   Locations

   12 in total

   Run by

   Target ALS Foundation, Inc.

   See if you can join NCT05137665 on ClinicalTrials.gov